位置:首页 > 蛋白库 > GCR_RABIT
GCR_RABIT
ID   GCR_RABIT               Reviewed;         772 AA.
AC   P59667;
DT   30-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   30-APR-2003, sequence version 1.
DT   03-AUG-2022, entry version 134.
DE   RecName: Full=Glucocorticoid receptor;
DE            Short=GR;
DE   AltName: Full=Nuclear receptor subfamily 3 group C member 1;
GN   Name=NR3C1; Synonyms=GRL;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lens epithelium;
RA   James E.R., Robertson L.L.;
RT   "Rabbit glucocorticoid receptor from lens epithelial cells.";
RL   Submitted (OCT-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   IDENTIFICATION IN A COMPLEX WITH NR3C1 AND FKBP4; PPID; PPP5C OR STIP1.
RX   PubMed=9195923; DOI=10.1074/jbc.272.26.16224;
RA   Silverstein A.M., Galigniana M.D., Chen M.S., Owens-Grillo J.K.,
RA   Chinkers M., Pratt W.B.;
RT   "Protein phosphatase 5 is a major component of glucocorticoid
RT   receptor.hsp90 complexes with properties of an FK506-binding
RT   immunophilin.";
RL   J. Biol. Chem. 272:16224-16230(1997).
CC   -!- FUNCTION: Receptor for glucocorticoids (GC). Has a dual mode of action:
CC       as a transcription factor that binds to glucocorticoid response
CC       elements (GRE), both for nuclear and mitochondrial DNA, and as a
CC       modulator of other transcription factors. Affects inflammatory
CC       responses, cellular proliferation and differentiation in target
CC       tissues. Involved in chromatin remodeling. Plays a role in rapid mRNA
CC       degradation by binding to the 5' UTR of target mRNAs and interacting
CC       with PNRC2 in a ligand-dependent manner which recruits the RNA helicase
CC       UPF1 and the mRNA-decapping enzyme DCP1A, leading to RNA decay. Could
CC       act as a coactivator for STAT5-dependent transcription upon growth
CC       hormone (GH) stimulation and could reveal an essential role of hepatic
CC       GR in the control of body growth. Mediates glucocorticoid-induced
CC       apoptosis. Promotes accurate chromosome segregation during mitosis. May
CC       act as a tumor suppressor. May play a negative role in adipogenesis
CC       through the regulation of lipolytic and antilipogenic gene expression.
CC       {ECO:0000250|UniProtKB:P04150, ECO:0000250|UniProtKB:P06537}.
CC   -!- SUBUNIT: Heteromultimeric cytoplasmic complex with HSP90AA1,
CC       HSPA1A/HSPA1B, and FKBP5 or another immunophilin such as PPID, STIP1,
CC       or the immunophilin homolog PPP5C (PubMed:9195923). Upon ligand binding
CC       FKBP5 dissociates from the complex and FKBP4 takes its place, thereby
CC       linking the complex to dynein and mediating transport to the nucleus,
CC       where the complex dissociates (PubMed:9195923). Probably forms a
CC       complex composed of chaperones HSP90 and HSP70, co-chaperones CDC37,
CC       PPP5C, TSC1 and client protein TSC2, CDK4, AKT, RAF1 and NR3C1; this
CC       complex does not contain co-chaperones STIP1/HOP and PTGES3/p23 (By
CC       similarity). Directly interacts with UNC45A (By similarity). Binds to
CC       DNA as a homodimer, and as heterodimer with NR3C2 or the retinoid X
CC       receptor (By similarity). Binds STAT5A and STAT5B homodimers and
CC       heterodimers (By similarity). Interacts with NRIP1, POU2F1, POU2F2 and
CC       TRIM28 (By similarity). Interacts with several coactivator complexes,
CC       including the SMARCA4 complex, CREBBP/EP300, TADA2L (Ada complex) and
CC       p160 coactivators such as NCOA2 and NCOA6 (By similarity). Interaction
CC       with BAG1 inhibits transactivation (By similarity). Interacts with
CC       HEXIM1 and TGFB1I1 (By similarity). Interacts with NCOA1 (By
CC       similarity). Interacts with NCOA3, SMARCA4, SMARCC1, SMARCD1, and
CC       SMARCE1 (By similarity). Interacts with CLOCK, CRY1 and CRY2 in a
CC       ligand-dependent fashion (By similarity). Interacts with CIART (By
CC       similarity). Interacts with RWDD3 (By similarity). Interacts with
CC       UBE2I/UBC9 and this interaction is enhanced in the presence of RWDD3
CC       (By similarity). Interacts with GRIP1 (By similarity). Interacts with
CC       NR4A3 (via nuclear receptor DNA-binding domain), represses
CC       transcription activity of NR4A3 on the POMC promoter Nur response
CC       element (NurRE) (By similarity). Directly interacts with PNRC2 to
CC       attract and form a complex with UPF1 and DCP1A; the interaction leads
CC       to rapid mRNA degradation (By similarity). Interacts with GSK3B (By
CC       similarity). Interacts with FNIP1 and FNIP2 (By similarity). Interacts
CC       (via C-terminus) with HNRNPU (via C-terminus) (By similarity).
CC       Interacts with MCM3AP (By similarity). Interacts (via domain NR LBD)
CC       with HSP90AA1 and HSP90AB1 (By similarity). In the absence of hormonal
CC       ligand, interacts with TACC1 (By similarity).
CC       {ECO:0000250|UniProtKB:P04150, ECO:0000250|UniProtKB:P06536,
CC       ECO:0000250|UniProtKB:P06537, ECO:0000269|PubMed:9195923}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P04150}. Nucleus
CC       {ECO:0000250|UniProtKB:P04150}. Mitochondrion
CC       {ECO:0000250|UniProtKB:P04150}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000250|UniProtKB:P04150}. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome {ECO:0000250|UniProtKB:P04150}.
CC       Note=After ligand activation, translocates from the cytoplasm to the
CC       nucleus (By similarity). In the presence of NR1D1 shows a time-
CC       dependent subcellular localization, localizing to the cytoplasm at ZT8
CC       and to the nucleus at ZT20 (By similarity). Lacks this diurnal pattern
CC       of localization in the absence of NR1D1, localizing to both nucleus and
CC       the cytoplasm at ZT8 and ZT20 (By similarity).
CC       {ECO:0000250|UniProtKB:P04150, ECO:0000250|UniProtKB:P06537}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a
CC       DNA-binding domain and a C-terminal ligand-binding domain. The ligand-
CC       binding domain is required for correct chromosome segregation during
CC       mitosis although ligand binding is not required.
CC       {ECO:0000250|UniProtKB:P04150}.
CC   -!- PTM: Acetylation by CLOCK reduces its binding to glucocorticoid
CC       response elements and its transcriptional activity. {ECO:0000250}.
CC   -!- PTM: Increased proteasome-mediated degradation in response to
CC       glucocorticoids. {ECO:0000250|UniProtKB:P04150}.
CC   -!- PTM: Phosphorylated in the absence of hormone; becomes
CC       hyperphosphorylated in the presence of glucocorticoid. The Ser-203,
CC       Ser-226 and Ser-399-phosphorylated forms are mainly cytoplasmic, and
CC       the Ser-211-phosphorylated form is nuclear. Phosphorylation at Ser-211
CC       increases transcriptional activity. Phosphorylation at Ser-203, Ser-226
CC       and Ser-399 decreases signaling capacity. Phosphorylation at Ser-399
CC       may protect from glucocorticoid-induced apoptosis. Phosphorylation at
CC       Ser-203 and Ser-211 is not required in regulation of chromosome
CC       segregation. May be dephosphorylated by PPP5C, attenuates NR3C1 action.
CC       {ECO:0000250|UniProtKB:P04150, ECO:0000250|UniProtKB:P06537}.
CC   -!- PTM: Ubiquitinated; restricts glucocorticoid-mediated transcriptional
CC       signaling. {ECO:0000250|UniProtKB:P06537}.
CC   -!- PTM: Sumoylation at Lys-277 and Lys-293 negatively regulates its
CC       transcriptional activity. Sumoylation at Lys-698 positively regulates
CC       its transcriptional activity in the presence of RWDD3. Sumoylation at
CC       Lys-277 and Lys-293 is dispensable whereas sumoylation at Lys-698 is
CC       critical for the stimulatory effect of RWDD3 on its transcriptional
CC       activity. Heat shock increases sumoylation in a RWDD3-dependent manner.
CC       {ECO:0000250|UniProtKB:P06536}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR3
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY161275; AAN75442.1; -; mRNA.
DR   RefSeq; NP_001075616.1; NM_001082147.1.
DR   AlphaFoldDB; P59667; -.
DR   SMR; P59667; -.
DR   BioGRID; 1171913; 1.
DR   STRING; 9986.ENSOCUP00000010039; -.
DR   PRIDE; P59667; -.
DR   GeneID; 100008890; -.
DR   KEGG; ocu:100008890; -.
DR   CTD; 2908; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   InParanoid; P59667; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0004883; F:nuclear glucocorticoid receptor activity; IEA:InterPro.
DR   GO; GO:0004879; F:nuclear receptor activity; ISS:UniProtKB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0005496; F:steroid binding; ISS:UniProtKB.
DR   GO; GO:1990239; F:steroid hormone binding; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; ISS:UniProtKB.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; ISS:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   Gene3D; 1.10.565.10; -; 1.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR001409; Glcrtcd_rcpt.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF02155; GCR; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00528; GLCORTICOIDR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromatin regulator; Cytoplasm; Cytoskeleton; DNA-binding;
KW   Isopeptide bond; Lipid-binding; Metal-binding; Methylation; Mitochondrion;
KW   Nucleus; Phosphoprotein; Receptor; Reference proteome; Steroid-binding;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..772
FT                   /note="Glucocorticoid receptor"
FT                   /id="PRO_0000053673"
FT   DOMAIN          519..753
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        416..481
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         416..436
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         452..476
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..415
FT                   /note="Modulating"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          39..82
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          132..186
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          480..772
FT                   /note="Interaction with CLOCK"
FT                   /evidence="ECO:0000250"
FT   REGION          482..518
FT                   /note="Hinge"
FT   REGION          494..513
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          527..692
FT                   /note="Interaction with CRY1"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        167..186
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         25
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P06537"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   MOD_RES         115
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06537"
FT   MOD_RES         136
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   MOD_RES         143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06537"
FT   MOD_RES         203
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   MOD_RES         211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   MOD_RES         226
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06537"
FT   MOD_RES         400
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   MOD_RES         475
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   MOD_RES         487
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   MOD_RES         489
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   MOD_RES         490
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   CROSSLNK        258
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   CROSSLNK        277
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   CROSSLNK        277
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   CROSSLNK        293
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   CROSSLNK        293
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
FT   CROSSLNK        414
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P06537"
FT   CROSSLNK        698
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:P04150"
SQ   SEQUENCE   772 AA;  84863 MW;  C16D6CF799F83148 CRC64;
     MDSKESLSPP GREEVPSSVL RPAERGNVMD LYKTLRGGAP VRVPASSPSL APAAQPDSKQ
     QRLAVDFPKG SASNAQQPDL SRAVSLSMGL YMGETETKVM GSDLAFPQQG QTSLSSGETD
     FRLLEESIAS LNRSASGADN PRSTAPAAGS AAPTEGFPKT HSDLASERQN PKGQTGGSAG
     SAKLHPTDQS TFDILQDLEF SGSPSKDRSE SPWRSDLLMD ENCLLSPLAG EDDPFLLEGN
     SSEDCKPLIL PDTKPKIKDN GDLILSNSNN VPLPQVKTEK EDFIELCTPG VIKQEKLGPV
     YCQASFSGAN IIGNKISAIS VHGVSTSGGQ MYHYDMNAQQ QEQKPLFNVI PPIPVGSENW
     NRCQGSGDDN LTSLGTMNFP GRSVFSNGYS SPGMRPDVSS PPSNSTTAAG PPPKLCLVCS
     DEASGCHYGV LTCGSCKVFF KRAVKGQHNY LCAGRNDCII DKIRRKNCPA CRYRKCLQAG
     MNLEARKTKK KIKGIQQTST GVSQETSENP SNRTVVPAAL PQLTPTLVSL LEVIEPEVLY
     AGYDSSVPDS TWRIMTTLNM LGGRQVIAAV KWAKAIPGFR NLHLDDQMTL LQYSWMFLMA
     FALGWRSYKQ SSGNMLCFAP DLVINEQRMT LPYMYDQCKH MLFVSSELKR LQVSYEEYLC
     MKTLLLLSTV PKEGLKSQEL FDEIRMTYIK ELGKAIVKRE GNSSQNWQRF YQLTKLLDSM
     HEVVENLLHY CFQTFLDKTM SIEFPEMLAE IITNQIPKYS NGNIKKLLFH QK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024